A detailed history of Ubs Oconnor LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 6,827 shares of BSX stock, worth $617,365. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,827
Holding current value
$617,365
% of portfolio
0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $19,918 - $22,932
-273 Reduced 3.85%
6,827 $572,000
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $518,441 - $598,367
-7,700 Reduced 52.03%
7,100 $546,000
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $287,136 - $342,070
-4,985 Reduced 25.2%
14,800 $1.01 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $1.54 Million - $1.83 Million
-31,607 Reduced 61.5%
19,785 $1.14 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $501,900 - $546,800
10,000 Added 24.16%
51,392 $2.71 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $2.06 Million - $2.26 Million
41,392 New
41,392 $2.24 Billion
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $442,287 - $490,744
-9,809 Reduced 17.57%
46,008 $2.3 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $561,277 - $669,957
-14,188 Reduced 20.27%
55,817 $0
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $2.31 Million - $6.91 Million
-63,000 Reduced 47.37%
70,005 $2.71 Billion
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $2.31 Million - $3.08 Million
65,476 Added 96.96%
133,005 $4.96 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $2.76 Million - $3.05 Million
67,529 New
67,529 $2.99 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.